{"id":"https://openalex.org/W190542260","doi":null,"title":"Generierung und In vitro Charakterisierung rekombinanter bispezifischer CD3 x NCAM und CD3 x VEGFR-2 Antik\u00f6rper f\u00fcr die Neuroblastomtherapie","display_name":"Generierung und In vitro Charakterisierung rekombinanter bispezifischer CD3 x NCAM und CD3 x VEGFR-2 Antik\u00f6rper f\u00fcr die Neuroblastomtherapie","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W190542260","mag":"190542260"},"language":"de","primary_location":{"id":"pmh:oai:USBKOELN.ub.uni-koeln.de:3003","doi":null,"is_oa":false,"landing_page_url":"https://kups.ub.uni-koeln.de/3003/1/Dissertation_AnkeKopacek.pdf","pdf_url":"https://kups.ub.uni-koeln.de/3003/1/Dissertation_AnkeKopacek.pdf","source":{"id":"https://openalex.org/S4306400371","display_name":"K\u00f6lner Universit\u00e4ts PublikationsServer (Universit\u00e4t zu K\u00f6ln)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210115942","host_organization_name":"Rhenish Institute for Environmental Research","host_organization_lineage":["https://openalex.org/I4210115942"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"doc-type:doctoralThesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065474043","display_name":"Anke Kopacek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Anke Kopacek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5065474043"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7002000212669373,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7002000212669373,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.26030001044273376,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9869999885559082},{"id":"https://openalex.org/keywords/okt3","display_name":"OKT3","score":0.8050000071525574},{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.75},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.49799999594688416},{"id":"https://openalex.org/keywords/tumor-vascularization","display_name":"tumor vascularization","score":0.5820000171661377},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.5619999766349792},{"id":"https://openalex.org/keywords/tumor-cell-lysis","display_name":"tumor cell lysis","score":0.34599998593330383}],"concepts":[{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.6805853247642517},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5446810126304626},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.5386175513267517},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.22443950176239014},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21473708748817444},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.10400733351707458},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.08780968189239502}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:USBKOELN.ub.uni-koeln.de:3003","doi":null,"is_oa":false,"landing_page_url":"https://kups.ub.uni-koeln.de/3003/1/Dissertation_AnkeKopacek.pdf","pdf_url":"https://kups.ub.uni-koeln.de/3003/1/Dissertation_AnkeKopacek.pdf","source":{"id":"https://openalex.org/S4306400371","display_name":"K\u00f6lner Universit\u00e4ts PublikationsServer (Universit\u00e4t zu K\u00f6ln)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210115942","host_organization_name":"Rhenish Institute for Environmental Research","host_organization_lineage":["https://openalex.org/I4210115942"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"doc-type:doctoralThesis"},{"id":"mag:190542260","doi":null,"is_oa":false,"landing_page_url":"https://kups.ub.uni-koeln.de/3003/1/Dissertation_AnkeKopacek.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":99,"referenced_works":["https://openalex.org/W39575425","https://openalex.org/W78913889","https://openalex.org/W125953517","https://openalex.org/W145810630","https://openalex.org/W153934429","https://openalex.org/W157457955","https://openalex.org/W201357455","https://openalex.org/W252128624","https://openalex.org/W1539571840","https://openalex.org/W1606356514","https://openalex.org/W1838901836","https://openalex.org/W1840766718","https://openalex.org/W1901831739","https://openalex.org/W1932572494","https://openalex.org/W1936323503","https://openalex.org/W1965744027","https://openalex.org/W1967170227","https://openalex.org/W1973284926","https://openalex.org/W1979653508","https://openalex.org/W1980603167","https://openalex.org/W1984615487","https://openalex.org/W1985645291","https://openalex.org/W1989053318","https://openalex.org/W1991180616","https://openalex.org/W1991764034","https://openalex.org/W1993575340","https://openalex.org/W1994863160","https://openalex.org/W1994957566","https://openalex.org/W1996820981","https://openalex.org/W2000292756","https://openalex.org/W2002296676","https://openalex.org/W2004918005","https://openalex.org/W2008383233","https://openalex.org/W2009259931","https://openalex.org/W2010111403","https://openalex.org/W2010415744","https://openalex.org/W2010979801","https://openalex.org/W2011370547","https://openalex.org/W2015344488","https://openalex.org/W2018309349","https://openalex.org/W2019137723","https://openalex.org/W2020192796","https://openalex.org/W2024280594","https://openalex.org/W2026100870","https://openalex.org/W2026118569","https://openalex.org/W2029067198","https://openalex.org/W2029424132","https://openalex.org/W2029705704","https://openalex.org/W2030522563","https://openalex.org/W2030745519","https://openalex.org/W2030853119","https://openalex.org/W2032144081","https://openalex.org/W2033635529","https://openalex.org/W2040972148","https://openalex.org/W2049418140","https://openalex.org/W2052914942","https://openalex.org/W2053247155","https://openalex.org/W2053375897","https://openalex.org/W2054383673","https://openalex.org/W2059410948","https://openalex.org/W2062464523","https://openalex.org/W2064360454","https://openalex.org/W2066639629","https://openalex.org/W2067495948","https://openalex.org/W2071870745","https://openalex.org/W2072311430","https://openalex.org/W2075097399","https://openalex.org/W2076917151","https://openalex.org/W2083494119","https://openalex.org/W2085756414","https://openalex.org/W2086146164","https://openalex.org/W2088164154","https://openalex.org/W2089316300","https://openalex.org/W2093852980","https://openalex.org/W2100525694","https://openalex.org/W2102140960","https://openalex.org/W2109103923","https://openalex.org/W2118513878","https://openalex.org/W2123541453","https://openalex.org/W2131515450","https://openalex.org/W2132604294","https://openalex.org/W2135046653","https://openalex.org/W2136574608","https://openalex.org/W2143824353","https://openalex.org/W2145132368","https://openalex.org/W2151384979","https://openalex.org/W2155018679","https://openalex.org/W2156480888","https://openalex.org/W2157691319","https://openalex.org/W2158316748","https://openalex.org/W2160325573","https://openalex.org/W2170181158","https://openalex.org/W2170379319","https://openalex.org/W2170758516","https://openalex.org/W2171445183","https://openalex.org/W2319962899","https://openalex.org/W2327522594","https://openalex.org/W2339584312","https://openalex.org/W2499673848"],"related_works":["https://openalex.org/W4411142580","https://openalex.org/W2026537544","https://openalex.org/W6962204500","https://openalex.org/W2275240354","https://openalex.org/W2136617071","https://openalex.org/W3152297325","https://openalex.org/W6887444983","https://openalex.org/W4313946460","https://openalex.org/W2905551210","https://openalex.org/W1579493769"],"abstract_inverted_index":{"Das":[0,64],"Neuroblastom":[1],"ist":[2,29,75],"weltweit":[3],"die":[4,25,78,83,108,111,197,388],"zweithaeufigste":[5],"maligne":[6],"Krebserkrankung":[7],"bei":[8,242,264],"Kindern.":[9],"Der":[10,149,289],"Einsatz":[11,31,98],"immuntherapeutischer":[12,102],"Behandlungsmethoden":[13],"stellt":[14],"eine":[15,41,165,302,319],"gro\u00dfe":[16],"Herausforderung":[17],"in":[18,156,189,193,214,296,339,346,350,366,400,433],"der":[19,30,89,97,157,175,177,185,194,212,215,253,265,297,316,330,337,351,378,381,390,393,401,438,451,473,493],"Klinik":[20],"dar.":[21],"Im":[22,469],"Hinblick":[23],"auf":[24,70,159,274,284,299,387,441,458,496,500],"Etablierung":[26,84],"antikoerperbasierender":[27],"Strategien":[28],"bispezifischer":[32,99,115],"CD3":[33,116,127],"x":[34,117,120,124,128,131,153,293,422,426,477],"TAA-Antikoerper":[35],"ein":[36,76,270],"vielversprechender":[37],"Ansatz.":[38],"Ihr":[39],"Potential,":[40],"T-Zellrezeptor-unabhaengige":[42],"Aktivierung":[43],"von":[44,59,85,88,101,171,204,250,308,325,342],"T-Zellen":[45,200,355],"zu":[46,56,207,221,232,276,356,407,417],"vermitteln":[47],"und":[48,113,122,162,188,218,223,345,404,424,443,466],"aktivierte":[49,224,410],"T-Effektorzellen":[50,226],"gegen":[51,229,414],"den":[52,230,415,510],"Tumor":[53,231,416],"zwecks":[54],"Zelllyse":[55,237],"richten,":[57],"kann":[58,94],"gro\u00dfem":[60],"therapeutischen":[61],"Nutzen":[62],"sein.":[63,104],"neurale":[65],"Zelladhaesionsmolek\u00fcl":[66],"NCAM,":[67],"das":[68],"nahezu":[69],"allen":[71],"Neuroblastomzellen":[72],"exprimiert":[73],"wird,":[74,93],"fuer":[77],"Therapie":[79],"relevantes":[80],"target-Antigen.":[81],"Da":[82],"Tumoren":[86],"ma\u00dfgeblich":[87],"VEGF/VEGFR-vermittelten":[90],"Vaskularisierung":[91],"beeinflusst":[92],"auch":[95],"hier":[96],"Antikoerper":[100,338,453,494],"Relevanz":[103],"Daran":[105],"orientiert,":[106],"umfasste":[107],"vorliegende":[109],"Arbeit":[110],"Herstellung":[112],"In-vitro-Charakterisierung":[114],"NCAM":[118],"(OKT-3/murin":[119],"ERIC-1/murin)":[121],"(UCHT-1/humanisiert":[123,130],"D29/humanisiert)":[125],"sowie":[126,137,463],"VEGFR-2":[129],"A7/murin)-Antikoerper":[132],"im":[133,362,395,430,456],"single":[134,138],"chain":[135,139],"Fv(bsscFv)-":[136],"(sc)-diabody-Format.":[140],"Die":[141,234,328,358,419,436,448,486],"bsscFv-Antikoerper":[142],"wurden":[143,428],"aus":[144,377],"stabil":[145,432,488],"produzierenden":[146],"Sp2/0-Myelomazellen":[147],"aufgereinigt.":[148],"r3V":[150,186,213,257],"bsscFv":[151,291],"(UCHT-1":[152,292],"A7)":[154],"zeigte":[155,295,315],"FACS-Titration":[158,298],"CD3-positiven":[160,300,459],"Jurkat-":[161],"VEGFR-2-positiven":[163,461],"PAE/KDR-Zellen":[164,192,220],"deutliche":[166,320],"Bindung":[167,304,321,450],"ab":[168,201,305,322],"einer":[169,202,306,323,340],"Konzentration":[170,203,307,324,341],"1":[172,205,309,343],"\u00b5g/ml.":[173,310,327],"In":[174,385],"Analyse":[176,329,487],"Proliferation":[178,331],"humaner":[179,332],"PBMCs":[180,334],"kam":[181],"zum":[182,506],"Ausdruck,":[183],"dass":[184,282,336,492],"allein":[187],"Gegenwart":[190,347,367],"inaktivierter":[191,348],"Lage":[195,352],"war,":[196,353],"Stimulation":[198,359,413],"CD3-positiver":[199],"\u00b5g/ml":[206,344],"aktivieren.":[208],"Des":[209],"Weiteren":[210],"war":[211,263,360,392,472],"Lage,":[216,402],"T-":[217,403],"VEGFR-2-positive":[219],"vernetzen":[222],"CD8-positive":[225],"nach":[227,412],"Il-2-Stimulation":[228],"richten.":[233,418],"ermittelte":[235],"spezifische":[236,449],"betrug":[238],"etwa":[239],"30":[240],"Prozent":[241],"einem":[243],"Effektor":[244],":":[245,248],"Zielzellen-Verhaeltnis":[246],"(E":[247],"T-Ratio)":[249],"30.":[251],"Bei":[252],"PBMC-Stimulation":[254],"mittels":[255],"des":[256,383],"erfolgte":[258],"diese":[259],"Effektorfunktion":[260],"nicht.":[261],"Ueberraschenderweise":[262],"Zytotoxizitaetsanalyse":[266],"mit":[267],"VEGFR-2-negativen":[268],"PAE/FLT1-Kontrollzellen":[269],"aehnlicher":[271],"Effekt":[272,374],"wie":[273],"PAE/KDR-Zielzellen":[275],"sehen.":[277],"Daten":[278],"deuten":[279],"darauf":[280],"hin,":[281],"dies":[283],"unspezifische":[285],"Faktoren":[286],"zurueckzufuehren":[287],"war.":[288],"r3N":[290,317,394],"D29)":[294],"Jurkatzellen":[301],"klare":[303],"Auf":[311],"NCAM-positiven":[312,464],"TE671-Zellen":[313,467],"hingegen":[314],"erst":[318],"80":[326],"CD56-depletierter":[333],"verdeutlichte,":[335],"IMR5-Zellen":[349,406],"CD3-positive":[354],"stimulieren.":[357],"jedoch":[361],"Vergleich":[363],"zur":[364],"PBMC-Proliferation":[365],"NCAM-negativer":[368],"LS-Kontrollzellen":[369],"nicht":[370,483,499],"signifikant":[371],"erhoeht.":[372],"Dieser":[373],"resultierte":[375],"mutma\u00dflich":[376],"schlechten":[379],"Bindungskapazitaet":[380],"anti-NCAM-Domaene":[382,391],"r3N.":[384],"Bezug":[386],"Bindungseigenschaften":[389],"Rahmen":[396],"dieser":[397],"Studie":[398],"weder":[399],"NCAM-positive":[405],"vernetzen,":[408],"noch":[409],"Effektorzellen":[411],"Antikoerperklone":[420],"UCHT-1":[421,425],"A7":[423],"D29":[427],"zusaetzlich":[429],"sc-diabody-Format":[431],"BHK21-Zellen":[434],"exprimiert.":[435],"Expression":[437],"diabody-Antikoerper":[439],"konnte":[440],"mRNA-":[442],"Proteinebene":[444,501],"deutlich":[445],"nachgewiesen":[446],"werden.":[447],"sekretierten":[452],"wurde":[454],"erfolgreich":[455],"FACS":[457],"Jurkat-,":[460],"PAE/KDR-":[462],"IMR5-":[465],"verifiziert.":[468],"Gegensatz":[470],"dazu":[471],"initial":[474],"untersuchte":[475],"OKT-3":[476],"ERIC-1":[478,507],"diabody":[479],"f\u00fcr":[480],"funktionale":[481],"Analysen":[482],"hinreichend":[484],"exprimierbar.":[485],"transfizierter":[489],"BHK21-Klone":[490],"ergab,":[491],"zwar":[495],"mRNA-,":[497],"aber":[498],"nachweisbar":[502],"ist.":[503],"Analoge":[504],"Studien":[505],"scFv":[508],"zeigten":[509],"gleichen":[511],"Befund.":[512]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}